Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Dowlais Group plc
-
CONDITIONS FOR SALE OF RIKSBANK CERTIFICATES
-
Form 8.5 (EPT/RI) - GlobalData plc
-
Form 8.5 (EPT/RI) - De La Rue plc
-
Announcement concerning large shareholders under the Danish Capital Markets Act
-
Integral Metals Reports Monazite-Dominant REE Mineralization at Woods Creek
-
ZA Miner Announces Trump Coin as a New Payment Method and Mining Option for Users
-
Nokia supplies private wireless to Maersk's fleet for real-time cargo tracking
-
New Analysis Published in Nature Medicine Demonstrates Advantages of Nationwide Coronary CTA Strategy with Heartflow FFRCT in Over 90,000 Patients with Coronary Artery Disease
-
Municipality Finance issues SEK 500 million notes under its MTN programme
-
Priothera Appoints Dr. Jens Hasskarl as Chief Medical Officer to Drive Late-Stage Clinical Development of Mocravimod, a S1P Receptor Modulator for Acute Myeloid Leukemia (AML)
-
Essential Pharma strengthens management team with appointment of Duncan Ferguson as Vice President, Commercial
-
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines
-
Hiab Corporation - Managers' transactions - Sra
-
Hiab Corporation - Managers' transactions - Sotamaa
-
Hiab Corporation - Managers' transactions - Pohjolainen-Hiltunen
-
Hiab Corporation - Managers' transactions - Moisio
-
Hiab Corporation - Managers' transactions - Lindholm
-
Hiab Corporation - Managers' transactions - Herlin
-
Hiab Corporation - Managers' transactions - Hankonen-Nybom
-
Hiab Corporation - Managers' transactions - Alström
-
Marimekko Day on 16 May at Esplanade Park – Featuring Artist Goldielocks
-
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
-
Progress on share buyback programme
-
Invitation to Enefit Green investor webinars presenting Q1 2025 interim results
-
Elis: Disclosure of trading in own shares occured from April 28 to May 2, 2025
-
Baltic Horizon Fund publishes interest rate applicable to the bonds for the next interest period
-
Appointment of Nominated & Financial Adviser
-
Transaction in Own Shares
-
Transactions Made Under the Share Buy-back Programme for Stolt-Nielsen Limited
-
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
-
Three-month interim report (Q1) 2025 (unaudited)
-
Q1 2025 INTERIM REPORT - 2025-TRANSITION PROGRESSING
-
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
-
International Petroleum Corporation Announces First Quarter 2025 Financial and Operational Results
-
Report for the three months ended 31 March 2025
-
Inbank unaudited financial results for Q1 2025
-
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
-
BW Offshore: 2025 Annual General Meeting – Notice
-
Viridien secures sale of Sercel Marlin Offshore Logistics solution to ONGC
-
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Philips delivers on Q1 results, with ongoing order intake growth
-
KH Group Plc’s Business Review January–March 2025: Moderate growth and improving profitability
-
Start of Day Message
-
Hexagon Purus ASA: Results for the first quarter 2025
-
Steady course in turbulent times
-
26/2025・Trifork Group: Interim report for the quarter ending 31 March 2025
-
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
-
Weekly progress on share repurchase program to cover share plans and reduce capital
-
Dividend Payments Ex-date of AS Tallinna Sadam

